ID119031166 / Ildong - LARVOL DELTA

Safety, Tolerability, and Pharmacokinetics of ID119031166M With the Exploration of Pharmacodynamic Effects (clinicaltrials.gov) - P1 | N=67 | Terminated | Sponsor: IlDong Pharmaceutical Co Ltd | Recruiting ➔ Terminated; Sponsor have decided to cancel the trial

Trial termination

Intestine FXR agonist ID119031166 modulates ethanol and bile acid metabolism in ethanol-fed hamsters (APASL 2024) - "Our findings suggest that ID119031166 modulates ethanol and bile acid metabolism by regulating key metabolic genes in chronic ethanol exposure."

Hepatology • Inflammation • ALDH1A1 • CYP2E1 • IL6 • TGFB1

Safety, Tolerability, and Pharmacokinetics of ID119031166M With the Exploration of Pharmacodynamic Effects (clinicaltrials.gov) - P1 | N=78 | Recruiting | Sponsor: IlDong Pharmaceutical Co Ltd

New P1 trial